159 related articles for article (PubMed ID: 35094384)
1. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
[TBL] [Abstract][Full Text] [Related]
2. CDK1 dependent phosphorylation of hTERT contributes to cancer progression.
Yasukawa M; Ando Y; Yamashita T; Matsuda Y; Shoji S; Morioka MS; Kawaji H; Shiozawa K; Machitani M; Abe T; Yamada S; Kaneko MK; Kato Y; Furuta Y; Kondo T; Shirouzu M; Hayashizaki Y; Kaneko S; Masutomi K
Nat Commun; 2020 Mar; 11(1):1557. PubMed ID: 32214089
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of hTERT protein in human tissues.
Yan P; Benhattar J; Seelentag W; Stehle JC; Bosman FT
Histochem Cell Biol; 2004 May; 121(5):391-7. PubMed ID: 15138842
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
[TBL] [Abstract][Full Text] [Related]
5. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
[TBL] [Abstract][Full Text] [Related]
6. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics.
March-Villalba JA; Martínez-Jabaloyas JM; Herrero MJ; Santamaria J; Aliño SF; Dasí F
PLoS One; 2012; 7(8):e43470. PubMed ID: 22916267
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
8. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
9. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.
Asaad NY; Abd El-Wahed MM; Mohammed AG
J Egypt Natl Canc Inst; 2006 Mar; 18(1):8-16. PubMed ID: 17237847
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of hTERT expression in non-small cell lung cancer.
Komiya T; Kawase I; Nitta T; Yasumitsu T; Kikui M; Fukuoka M; Nakagawa K; Hirashima T
Int J Oncol; 2000 Jun; 16(6):1173-7. PubMed ID: 10811992
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Zalewska-Ziob M; Dobija-Kubica K; Biernacki K; Adamek B; Kasperczyk J; Bruliński K; Ostrowska Z
Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of the detection of hTERT mRNA in renal tumors.
Martínez-Sanchíz C; García-Olmo DC; Picazo-Martínez MG; Nam-Cha SY; Giménez-Bachs JM; Flores-Bautista AB; Díaz-Piqueras Á; Salinas-Sánchez AS
Urol Oncol; 2019 Oct; 37(10):749-757. PubMed ID: 30975552
[TBL] [Abstract][Full Text] [Related]
14. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
[TBL] [Abstract][Full Text] [Related]
15. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
[TBL] [Abstract][Full Text] [Related]
16. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
17. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
18. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
